Drug safety watch for kids with rare swelling disorder
NCT ID NCT05509569
Summary
This study monitored children and teenagers in Japan who received Icatibant injections to treat sudden attacks of hereditary angioedema (HAE), a condition causing severe swelling. The main goal was to check for side effects and see how well the treatment worked to resolve these attacks. Doctors observed 32 young patients for three months after their first dose, tracking any problems and how quickly their symptoms went away.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEREDITARY ANGIOEDEMA (HAE) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Takeda selected site
Tokyo, Tokyo, Japan
Conditions
Explore the condition pages connected to this study.